Showing 721-730 of 8076 results for "".
Nemluvio Gains Two Major Indications in Europe
https://practicaldermatology.com/series/dermwire-tv/nemluvio-gains-two-major-indications-in-europe/32982/In this week's DermwireTV, Nemluvio is approved for two new indications in Europe; new patient-centric guidelines for generalized pustular psoriasis (GPP) management are unveiled; and in our C-Suite Chats feature, we are joined by the Co-Founder and CEO of Veradermics.Dr. Tsao, Dr. Friedlander Recap Biggest Developments for Maui Derm
https://practicaldermatology.com/conferences/maui-derm-hawaii-2025/dr-tsao-dr-friedlander-recap-biggest-developments-for-maui-derm/32913/The development of new therapeutics for dermatologic conditions in recent years has been so prolific that Hensin Tsao, MD, PhD, used a “Maui Journal of Medicine” theme for his conference-opening presentation at the Maui Derm Hawaii 2025 meeting in Maui, Hawaii.- Risk Stratification Testing for Melanomahttps://practicaldermatology.com/series/c-suite-chats/risk-stratification-testing-for-melanoma/32838/Derek Maetzold, president and CEO of Castle Biosciences, discusses the importance of personalized management and treatment approaches for patients diagnosed with melanoma, and how gene expression profile testing can help.
Combination Treatment: Dr. Shamban
https://practicaldermatology.com/conferences/maui-derm-hawaii-2025/combination-treatment-dr-shamban/32685/Ava Shamban, MD, talks about the combination treatments—such as energy-based devices, peels, and laser-assisted drug delivery—that she covered in "What's My Treatment? How to Combine Dermal Filler, Neuromodulators, Laser/Light/RF Devices/Microneedling and Cosmeceuticals Symposium" at Maui Derm 2025.Improving Treatment Capabilities for Vitiligo
https://practicaldermatology.com/series/c-suite-chats/improving-treatment-capabilities-for-vitiligo/29745/David Domzalski, CEO and President of Vyne Therapeutics, discusses what makes vitiligo difficult to treat and how his company is working to address those challenges.Chronic Hand Eczema Treatment Landscape
https://practicaldermatology.com/series/c-suite-chats/chronic-hand-eczema-treatment-landscape/29126/Jacob Thyssen, MD, PhD, Chief Scientific Officer at Leo Pharma, talks about the incidence of chronic hand eczema and the advantage that delgocitinib provides compared to other treatment options.Cosmetic Benefits and Post-Treatment
https://practicaldermatology.com/series/pdt-in-practice/cosmetic-benefits-and-post-treatment/29117/Dr. Joel L. Cohen describes the cosmetic benefits of photodynamic therapy and the post-treatment considerations involved.PDT vs Topical Therapies for Pre-Cancerous Areas
https://practicaldermatology.com/series/pdt-in-practice/pdt-vs-topical-therapies-pre-cancerous-areas/26992/Dr. Hamza D. Bhatti, a board-certified dermatologist and dually accredited fellowship-trained Mohs micrographic surgeon and cosmetic dermatologic surgeon, discusses the advantages that photodynamic therapy (PDT) offers in terms of downtime and ease of compliance.What's New in Topical Treatment for Plaque Psoriasis?
https://practicaldermatology.com/conferences/maui-derm-2024/whats-new-in-topical-treatment-for-plaque-psoriasis/20235/Linda Stein Gold, MD, director of dermatology clinical research at Henry Ford Health, discusses what’s new in topical treatment of plaque psoriasis and the importance of an “elegant vehicle” for patients to use in their care regimens.Is There Evidence that Topical Formulations Can Support the Microbiome?
https://practicaldermatology.com/topics/atopic-dermatitis/is-there-evidence-that-topical-formulations-can-support-the-microbiome/19826/There is a growing body of research on the importance of the microbiome as well as the potential to support a healthy microbiome through topical product selection, Dr. Friedman says.